StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) income statement

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx Holdings plc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
46.3%
Net margin
19.9%
Return on equity, FY2025
-368.2%

Financial strength

Current ratio
3.76
Debt to equity
–
Debt to assets
25.2%
Cash to current liabilities
246.4%

Valuation

P/E ratio
11.7
Price to sales
2.01
Price to book
–
Dividend yield
–

See a number that looks wrong?